Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Journal of the American Heart Association
|
October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
Saket Girotra, Amanda Stebbins, Lisa Wruck, et al.
Atherosclerosis
|
September 7, 2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)
Girum Mekonnen, Salim S Hayek, Puja K Mehta, et al.
Journal of the American Heart Association
|
June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Circulation. Cardiovascular Interventions
|
July 28, 2023
EXACT Trial: Results of the Phase 1 Dose-Escalation Study
Thomas J Povsic, Timothy D Henry, Jay H Traverse, et al.
Diabetes Care
|
September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial
Dennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
Clinical Pharmacology and Therapeutics
|
April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation
Cameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology
|
April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE Score
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
American Heart Journal
|
June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Kamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
JAMA
|
March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial
Emerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA
|
November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Journal of the American Heart Association
|
October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
Saket Girotra, Amanda Stebbins, Lisa Wruck, et al.
Atherosclerosis
|
September 7, 2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)
Girum Mekonnen, Salim S Hayek, Puja K Mehta, et al.
Journal of the American Heart Association
|
June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Circulation. Cardiovascular Interventions
|
July 28, 2023
EXACT Trial: Results of the Phase 1 Dose-Escalation Study
Thomas J Povsic, Timothy D Henry, Jay H Traverse, et al.
Diabetes Care
|
September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial
Dennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
Clinical Pharmacology and Therapeutics
|
April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation
Cameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology
|
April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE Score
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
American Heart Journal
|
June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Kamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
JAMA
|
March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial
Emerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA
|
November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Page
of 12